Adherent lipopolysaccharide inhibits the osseointegration of orthopedic implants by impairing osteoblast differentiation

Bone

Volumn 52, Issue 1, 2013, Pages 93-101

  Bonsignore, Lindsay A ^a   Anderson, J Robert ^a   Lee, Zhenghong ^a   Goldberg, Victor M ^a   Greenfield, Edward M ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bacterial debris; Lipopolysaccharide; Orthopedic implants; Osseointegration; Osteoblasts

Indexed keywords

LIPOPOLYSACCHARIDE; TITANIUM; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIUM CONTAMINATION; BIOMECHANICS; BONE DEVELOPMENT; BONE REGENERATION; CELL ADHESION; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; GRAM NEGATIVE BACTERIUM; GROWTH INHIBITION; IN VITRO STUDY; MINERALIZATION; MOUSE; NONHUMAN; ORTHOPEDIC IMPLANT; OSTEOBLAST; SIGNAL TRANSDUCTION;

3T3 CELLS; ANIMALS; CELL DIFFERENTIATION; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; OSSEOINTEGRATION; OSTEOBLASTS; PROSTHESES AND IMPLANTS; TITANIUM;

EID: 84867067601     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2012.09.011     Document Type: Article

References (44)

1. Bauer T., Schils J. The pathology of total joint arthroplasty.II. Mechanisms of implant failure. Skeletal Radiol 1999, 28:483-497.
2. Albrektsson T., Branemark P., Hansson H., Lindstrom J. Osseointegrated titanium implants. Requirements for ensuring a long-lasting, direct bone-to-implant anchorage in man. Acta Orthop Scand 1981, 52:155-170.
3. Branemark P. Osseointegration and its experimental background. J Prosthet Dent 1983, 50:399-410.
4. Puleo D., Nanci A. Understanding and controlling the bone-implant interface. Biomaterials 1999, 20:2311-2321.
5. Branemark R., Branemark P., Rydevik B., Myers R. Osseointegration in skeletal reconstruction and rehabilitation: a review. J Rehabil Res Dev 2001, 38:175-181.
6. Ryd L., Albrektsson B., Carlsson L., Dansgard F., Herberts P., Lindstrand A., Regner L., Toksvig-Larsen S. Roentgen stereophotogrammetric analysis as a predictor of mechanical loosening of knee prostheses. J Bone Joint Surg 1995, 77B:377-383.
7. Schmalzried T., Jasty M., Harris W. Periprosthetic bone loss in total hip arthroplasty. Polyethylene wear debris and the concept of the effective joint space. J Bone Joint Surg 1992, 74A:849-863.
8. Daniel A., Kimmelman E. The FDA and Worldwide Quality System Requirements Guidebook for Medical Devices 2008, ASQ Quality Press, Milwaukee. 2nd ed.
9. Spiegelberg S. How clean is clean enough?. ASTM Workshop of Medical Device Cleanliness, San Antonio 2010.
10. Spiegelberg S. ASTM activities for assessing cleanliness of medical devices. Medical device materials 2004, 125-126. ASM International, Materials Park. S. Shrivastava (Ed.).
11. Arys A., Philippart C., Dourov N., He Y., Le Q., Pireaux J. Analysis of titanium dental implants after failure of osseointegration: combined histological, electron microscopy, and X-ray photoelectron spectroscopy approach. J Biomed Mater Res 1998, 43:300-312.
12. Bonsignore L., Colbrunn R., Tatro J., Messerschmitt P., Hernandez C., Goldberg V., Stewart M., Greenfield E. Surface contaminants inhibit osseointegration in a novel murine model. Bone 2011, 49:923-930.
13. Williams D. Endotoxins and medical devices: the significance of dead bacteria. Med Device Technol 2003, 14:8-11.
14. Nelson S., Knoernschild K., Robinson F., Schuster G. Lipopolysaccharide affinity for titanium implant biomaterials. J Prosthet Dent 1997, 77:76-82.
15. Ragab A., Van De Motter R., Lavish S., Goldberg V., Ninomiya J., Carlin C., Greenfield E. Measurement and removal of adherent endotoxin from titanium particles and implant surfaces. J Orthop Res 1999, 17:803-809.
16. Lee M., Kim Y. Signaling pathways downstream of pattern-recognition receptors and their cross talk. Annu Rev Biochem 2007, 76:447-480.
17. Lu Y., Yeh W., Ohashi P. LPS/TLR4 signal transduction pathway. Cytokine 2008, 42:145-151.
18. Zahringer U., Lindner B., Inamura S., Heine H., Alexander C. TLR2 - promiscuous or specific? A critical re-evaluation of a receptor expressing apparent broad specificity. Immunobiology 2008, 213:205-224.
19. US Department of health and human services/Public Health services/Food and Drug Administration Guideline on validation of the limulus amebocyte lysate test as an end-product endotoxin test for human and animal parenteral drugs, biological products, and medical devices 1987, 1-30.
20. Ross V., Twohy C. Endotoxins and medical devices. Prog Clin Biol Res 1985, 189:267-281.
21. Orthopaedic Device Forum Meeting Summation Report, Bethesda 2003.
22. Campbell P., Mirra J., Catelas I. Histopathology of tissues from Inter-Op acetabular sockets. Trans. Orthop. Res. Soc. 2002, 27:187.
23. Kadono H., Kido J., Kataoka M., Yamauchi N., Nagata T. Inhibition of osteoblastic cell differentiation by lipopolysaccharide extract from Porphyromonas gingivalis. Infect Immun 1999, 67:2841-2846.
24. Loomer P., Ellen R., Tenenbaum H. Characterization of inhibitory effects of suspected periodontopathogen on osteogenesis in vitro. Infect Immun 1995, 63:3287-3296.
25. Xing Q., Ye Q., Fan M., Zhou Y., Xu Q., Sandham A. Porphyromonas gingivalis lipopolysaccharide inhibits the osteoblastic differentiation of preosteoblasts by activating Notch1 signaling. J Cell Physiol 2010, 225:106-114.
26. Bandow K., Maeda A., Kakimoto K., Kusuyama J., Shamoto M., Ohnishi T., Matsuguchi T. Molecular mechanisms of the inhibitory effect of lipopolysaccharide (LPS) on osteoblast differentiation. Biochem Biophys Res Commun 2010, 402:755-761.
27. Pevsner-Fischer M., Morad V., Cohen-Sfady M., Rousso-Noori L., Zanin-Zhorov A., Cohen S., Cohen I., Zipori D. Toll-like receptors and their ligands control mesenchymal stem cell functions. Blood 2007, 109:1422-1432.
28. Nouneh R., Wataha J., Hanes P., Lockwood P. Effect of lipopolysaccharide contamination on the attachment of osteoblast-like cells to titanium and titanium alloy in vitro. J Oral Implantol 2001, 27:174-179.
29. Nalepka J., Greenfield E. Detection of bacterial endotoxin in human tissues. Biotechniques 2004, 37:413-417.
30. Takeuchi O., Hoshino K., Kawai T., Sanjo H., Takada H., Ogawa T., Takeda K., Akira S. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 1999, 11:443-451.
31. Hise A., Daehnel K., Gillette-Ferguson I., Cho E., McGarry H., Taylor M., Golenbock D., Fitzgerald K., Kazura J., Pearlman E. Innate immune responses to endosymbiotic Wolbachia bacteria in Brugia malayi and Onchocerca volvulus are dependent on TLR2, TLR6, MyD88, and Mal, but not TLR4, TRIF, or TRAM. J Immunol 2007, 178:1068-1076.
32. Greenfield E., Beidelschies M., Tatro J., Goldberg V., Hise A. Bacterial pathogen-associated molecular patterns stimulate biological activity of orthopaedic wear particles by activating cognate Toll-like receptors. J Biol Chem 2010, 285:32378-32384.
33. Rozen S., Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Bioinformatics methods and protocols: methods in molecular biology 2000, 365-386. Humana Press, Totowa. S. Krawetz, S. Misener (Eds.).
34. Dai J., He P., Chen X., Greenfield E. TNFalpha and PTH utilize distinct mechanisms to induce IL-6 and RANKL expression with markedly different kinetics. Bone 2006, 38:509-520.
35. Giulietti A., Overbergh L., Valckx D., Decallonne B., Bouillon R., Mathieu C. An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods 2001, 25:386-401.
36. Wang Y., Liu Y., Maye P., Rowe D. Examination of mineralized nodule formation in living osteoblastic cultures using fluorescent dyes. Biotechnol Prog 2006, 22:1697-1701.
37. Hirschfeld M., Ma Y., Weis J., Vogel S., Weis J. Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. J Immunol 2000, 165:618-622.
38. Uehara A., Yang S., Fujimoto Y., Fukase K., Kusumoto S., Shibata K., Sugawara S., Takada H. Muramyldipeptide and diaminopimelic acid-containing desmuramylpeptides in combination with chemically synthesized Toll-like receptor agonists synergistically induced production of interleukin-8 in a NOD2- and NOD1-dependent manner, respectively, in human monocytic cells in culture. Cell Microbiol 2005, 7:53-61.
39. Yang S., Tamai R., Akashi S., Takeuchi O., Akira S., Sugawara S., Takada H. Synergistic effect of muramyldipeptide with lipopolysaccharide or lipoteichoic acid to induce inflammatory cytokines in human monocytic cells in culture. Infect Immun 2001, 69:2045-2053.
40. Kawai T., Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010, 11:373-384.
41. Williams K. Depyrogenations validation, pyroburden and endotoxin removal. Endotoxins: pyrogens, LAL testing and depyrogenation 2007, 301-328. Informa Healthcare USA, Inc., New York. K. Williams (Ed.).
42. Gorbet M., Sefton M. Endotoxin: the uninvited guest. Biomaterials 2005, 26:6811-6817.
43. Matzinger P. Friendly and dangerous signals: is the tissue in control?. Nat Immunol 2007, 8:11-13.
44. Bianchi M. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 2007, 81:1-5.